Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2378 of 5804
-
New study uses advanced scans to see how prostate cancer responds to radiation
Knowledge-focused Recruiting nowThis study aims to evaluate the role of PSMA-PET and circulating tumor DNA (ctDNA) in monitoring prostate cancer progression and response to radiotherapy (RT). Specifically, it investigates how often early progression is detected on PSMA-PET before PSA rise, examines PET response…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Probiotic pill may cut Kids' sore throat episodes
Disease control CompletedThis prospective, multicenter, randomized, double-blind, placebo-controlled, cross-over clinical trial will evaluate the efficacy and safety of Streptococcus salivarius Evol12® (Bactoblis® Evol) in reducing the recurrence and duration of acute febrile adenotonsillitis in children…
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Light therapy may ease radiation mouth pain for oral cancer patients
Symptom relief Recruiting nowThe goal of this study is to describe the effect of photobiomodulation (PBM) on the incidence and severity of oral mucositis in post-operative oral cancer patients receiving radiotherapy +/- chemotherapy. Participants will receive PBM treatment five times a week throughout the c…
Phase: NA • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Tiny liner could stop aneurysm leaks after surgery
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and feasibility of the Cygnum Aneurysm Sac Management Device in patients with abdominal aortic aneurysms treated with endovascular aneurysm repair (EVAR). The main questions it aims to answer are: 1. Is the Cygnum device …
Phase: NA • Sponsor: Life Seal Vascular Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug under observation for rare genetic disorder
Disease control ENROLLING_BY_INVITATIONProspective observational study developed to generate more evidence of the safety profile, clinical characteristics and outcomes of patients with PWS treated with VYKAT XR.
Sponsor: Soleno Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could one insulin shot a day be enough for gestational diabetes?
Disease control Recruiting nowThe goal of this clinical trial is to see if diabetes in pregnancy can be treated with once daily dosing of insulin instead of once daily dosing plus insulin with meals. The main question this study aims to answer is: 1. Can a once daily dose of long-acting insulin control blood…
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Fish oil compound may unclog inflamed arteries in obese patients
Disease control Recruiting nowCardiovascular risk factors such as obesity, diabetes, high blood pressure, high cholesterol, or smoking are associated with an increased risk of events such as myocardial infarction, stroke, or peripheral artery disease. Lifestyle and dietary measures, as well as pharmacological…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
AI coaches knee patients: ChatGPT-5, gemini, and DeepSeek put to the test in rehab trial
Symptom relief CompletedThis randomized, four-arm clinical trial will investigate the effects of large language model (LLM)-assisted exercise prescriptions integrated with conventional physiotherapy on pain, function and quality of life in adults with degenerative knee disease. Participants will be rand…
Phase: NA • Sponsor: Kirsehir Ahi Evran Universitesi • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
New combo therapy aims to tackle postpartum depression and incontinence without drugs
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate if the combined treatment with EXOMIND (BTL-699-2) and EMSELLA (HPM-6000UF) devices is able to improve depressive symptoms and urinary incontinence in women who delivered a healthy, singleton infant 2-60 months before enrollment in t…
Phase: NA • Sponsor: BTL Industries Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New drug may help pancreatic surgery patients recover faster
Symptom relief Recruiting nowExploring the effectiveness and safety of early use of Ariceptinfen after pancreaticoduodenectomy in alleviating postoperative pain and promoting recovery of patients. Main objective: To explore the analgesic effect of Anricfen after pancreaticoduodenectomy. Secondary objective…
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Ear seeds and steroids: a new combo to fight chemo sickness?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if auricular point stimulation plus dexamethasone works to effectively prevent or suppress nausea and vomiting caused by gemcitabine combined with paclitaxel protein-bound in pancreatic cancer treatment. It will also learn about the sa…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Could an infrared hat tame epilepsy seizures?
Symptom relief Recruiting nowDrug-resistant epilepsy represents roughly 40% of people with epilepsy. It is very challenging to stop seizures in this condition, and the treatment options are limited. This study aims to investigate a new treatment that involves using infra-red light. In animals, this treatment…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Smart inhalers and video visits could transform Kids' asthma care
Disease control Recruiting nowThis pilot study aims to explore whether a digital approach to managing childhood asthma using connected inhalers and video consultations triggered by alerts from these devices - could work as well as standard in-person care. The connected inhalers track when children use their d…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can cutting carbs help teens beat diabetes?
Disease control Recruiting nowThe purpose of this project is to test the effect of a low carb diet compared to standard carb diet among adolescents with T2D over a 24-week period.
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
TB survivors enroll in study to predict recurrence
Knowledge-focused Recruiting nowAs part of the ongoing efforts within the Rapid Research in Diagnostics Development for TB Network (R2D2 TB Network) study, the Candidate Clinical Correlate as Prognostic Outcome for TB (C3PO) study serves as a supplement aimed at evaluating predictors and novel biomarkers of rec…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
New device aims to quiet an overactive bladder without drugs
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if a vaginal radiofrequency (RF) device called MORPHEUSV works to treat overactive bladder (OAB) in women. Researchers also want to learn how safe the device is for this indication. This study will include women ages 22 to 80 who have h…
Phase: NA • Sponsor: InMode MD Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Ant venom allergy treatment: does it last?
Knowledge-focused Recruiting nowJack Jumper ant (JJA) venom allergy is a uniquely Australian medical condition. It is the leading cause of venom allergy and affects up to three per cent of the population. 70 percent of people with JJA allergy will have another reaction on a repeat sting and this sensitivity app…
Phase: PHASE4 • Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
New combo therapy aims to restore arm movement in stroke survivors
Symptom relief Recruiting nowThis study aims to evaluate the effectiveness of two rehabilitation techniques-Sensory Augmentation (using mirror therapy) and Neuromodulation (using transcranial direct current stimulation, tDCS)-in improving motor recovery among stroke survivors. Stroke often results in long-te…
Phase: NA • Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Kitchen spices meet science: can curcumin and CoQ10 gels stop mouth cancer before it starts?
Disease control Recruiting nowOral leukoplakia (OL) is recognized as the most common potentially malignant disorder of the oral mucosa. The pathogenesis of OL is complex and multifactorial, with oxidative stress playing a central role. Topical antioxidants have gained attention as therapeutic options to help …
Phase: NA • Sponsor: Alexandria University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New study tracks psoriasis Drug's Real-World impact on diverse skin types
Knowledge-focused Recruiting nowThis is a multi-centre, non-interventional, open-label, prospective observational study that will be conducted across Canada over 52-week duration. Approximately 80 patients who are initiating tildrakizumab as part of their routine care through the ILUMYA SUPPORT® Program and mee…
Sponsor: Chronicle Academy • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC